Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Conestoga Small Cap Composite Joe Monahan | “In early June, SLP announced that it was executing a restructuring plan that would eliminate 10% of its workforce to improve operating efficiency and lower costs. The company estimated that these actions would save approximately $4.3 million. This action signaled continued end market weakness. The company also announced that it had named a new Chief Revenue Officer. In the middle of June, the company announced preliminary 3Q results which were significantly below estimates. The combination of these announcements caused us to reduce our position in the company. BSD Analysis: Simulations Plus is an indispensable drug development software provider, operating a high-margin, recurring revenue model built on computational modeling and simulation (M&S) platforms. The core investment thesis is that its software, particularly the GastroPlus and DILIsym Suites, is becoming a non-negotiable compliance and efficiency tool for pharmaceutical regulatory submissions, giving it immense pricing power. The company's pivot to AI-enabled workflows and cloud deployment is designed to accelerate cross-product adoption and unlock new enterprise contracts, driving structural margin expansion. SLP is a critical "picks and shovels" play on the biopharma R&D boom, providing essential, high-moat software.” | BULL | Q2 2025 Jun 30, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
